| Filed On | Filing |
|---|---|
| 31 May 2024 |
8-K/A: Financial Statements and Exhibits
On March 25, 2024, NovaBay Pharmaceuticals, Inc. (the “Company” or “NovaBay”) completed the sale of its wholly-owned subsidiary, DERMAdoctor, LLC, a Missouri limited liability company (“DERMAdoctor”) (the “DERMAdoctor Divestiture”). |
| 01 Dec 2021 | 8-K/A: Financial Statements and Exhibits |
| 22 Jan 2014 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 21 Dec 2010 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 16 May 2008 | 8-K/A: Results of Operations and Financial Condition |
| 15 Jan 2008 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
